Using AI, we identified publications that likely reported a testing or mutation rate, filtered publications for cancer type, and identified sentences that likely reported rates. Rates and covariates ...
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions We matched 147 multigene panel patients to controls, ...
NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the ...
Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...
BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon or ...
@mooner As a heads up on the genetic testing, I suggest bringing (or better yet also uploading to MyChart) the contact information for the pathologist who identified ameloblastoma. MDA was able to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results